Detalhe da pesquisa
1.
Virological patterns of HCV patients with failure to interferon-free regimens.
J Med Virol
; 90(5): 942-950, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315640
2.
Suprarenal solitary fibrous tumor associated with a NF1 gene mutation mimicking a kidney neoplasm: implications for surgical management.
World J Surg Oncol
; 12: 87, 2014 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24708790
3.
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy.
Infect Dis Poverty
; 13(1): 39, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38802954
4.
Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis.
Liver Int
; 33(6): 834-42, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23590253
5.
Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation.
Clin Gastroenterol Hepatol
; 15(11): 1800-1802, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28552801
6.
Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis.
PLoS One
; 17(3): e0265178, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294954
7.
Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series.
Pathogens
; 11(8)2022 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36014981
8.
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results.
Expert Rev Gastroenterol Hepatol
; 15(9): 1057-1063, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33573411
9.
Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare.
Infez Med
; 17(2): 105-8, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19602924
10.
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment.
Antivir Ther
; 24(7): 485-493, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30758299
11.
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Am J Gastroenterol
; 103(8): 1966-72, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18637087
12.
Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP).
Infect Dis (Lond)
; 50(2): 125-132, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851249
13.
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
Saudi J Gastroenterol
; 24(1): 25-29, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451181
14.
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
Viruses
; 10(7)2018 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987240
15.
Therapy of chronic hepatitis B: focus on telbivudine.
Dig Liver Dis
; 39 Suppl 3: S372-8, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18063258
16.
Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis B.
World J Gastroenterol
; 13(42): 5642-7, 2007 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-17948940
17.
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.
Antivir Ther
; 22(7): 551-558, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28165327
18.
HBsAg seroconversion after pegylated interferon alfa 2a rescue in a lamivudine-resistant patient with HBeAg-negative chronic hepatitis B and favourable IL28-B genotype.
Infez Med
; 24(2): 144-6, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27367326
19.
[Prevalence and risk factors for bacteriuria in patients with cirrhosis]. / Prevalenza e fattori di rischio della batteriuria in pazienti con cirrosi.
Infez Med
; 13(2): 103-8, 2005 Jun.
Artigo
em Italiano
| MEDLINE | ID: mdl-16220030
20.
Case report: effect of antileishmanial treatment on hepatitis C viraemia in a visceral leishmaniasis patient with chronic hepatitis C.
Trans R Soc Trop Med Hyg
; 97(5): 559-60, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-15307426